Download the Complete Report Here By Rayk Riechmann Imagine hundreds of drones managed by one operator, complete with fully-autonomous navigation and AI-coordinated swarm operations. What may have sounded like science fiction a couple of years ago is now combat tested...

Read Exec Edge’s Coverage on The Drone Defense Supercycle Here Subscribe to Our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com Rayk@capmarketsmedia.com  

By Daniella Parra Amer Sports Inc. (NYSE:AS) said fourth quarter net income surged to $131.5M, up from $15.4M a year earlier, while revenue climbed 28.5% to $2.10B, topping analyst expectations. Full year net income rose to $427.4M as revenue increased...

By Daniella Parra Chicago-style chain Portillo’s Inc. (Nasdaq: PTLO) said fourth quarter total revenue increased 0.6% to $185.7 million, and fiscal 2025 total revenue rose 3%. Same-restaurant sales decreased by 3.3% and operating income to $10.3 million, a decrease of...

Enzo Villani, Executive Chairman and Chief Investment Officer of AlphaTON Capital By Exec Edge Research Staff AlphaTON Capital Corp. (ATON) has been assigned a $2 per share price target by broker H.C. Wainwright & Co., indicating a fivefold potential upside...

By John Jannarone World Gym Corp. (TAI: 2762.TW) reported a surge full-year net profit driven by higher revenue, with the fourth quarter finishing the year out strong. The company, which owns the World Gym brand with over 280 locations across...

Read Exec Edge’s Initiation on STKE Here Subscribe to Our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com Rayk@capmarketsmedia.com

Key Takeaways: Three BDCs managed by Blue Owl Capital announced a $1.4 billion sale of partial assets at fair value as of February 12th, equivalent to 99.7% of par value Proceeds from the sale provide liquidity to OBDC II shareholders,...

By Karen Roman SkylineDx said its Merlin CP-GEP molecular test is uniquely recognized by the National Comprehensive Cancer Network (NCCN) for predictive use in select T1 and T2 melanoma patients. The test provides informed risk stratification and helps physicians better understand...

By Karen Roman Upbound Group, Inc. (NASDAQ: UPBD) said total revenue increased 11% in the fourth quarter of 2025 to reach $1.2 billion while earnings per share were $1.01, both metrics surpassing analysts’ estimates. Net cash by operating activities was...